These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 2436780
1. Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas. Popper H, Wirnsberger G, Hoefler H, Denk H. Cancer Detect Prev; 1987; 10(3-4):167-74. PubMed ID: 2436780 [Abstract] [Full Text] [Related]
2. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Ordóñez NG. Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877 [Abstract] [Full Text] [Related]
3. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms]. Ratto GB, Capponi G, De Grandi R, Augeri C, Secco GB, Fardelli R. Minerva Chir; 1990 Oct 31; 45(20):1265-72. PubMed ID: 1964495 [Abstract] [Full Text] [Related]
4. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study. Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardieri E. Eur J Clin Chem Clin Biochem; 1994 Mar 31; 32(3):189-99. PubMed ID: 7518259 [Abstract] [Full Text] [Related]
5. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions. al-Saffar N, Hasleton PS. Eur Respir J; 1990 Oct 31; 3(9):997-1001. PubMed ID: 1705232 [Abstract] [Full Text] [Related]
6. Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas--a clinicomorphological study of 158 cases. Vortmeyer AO, Preuss J, Padberg BC, Kastendieck H, Schröder S. Anticancer Res; 1991 Oct 31; 11(2):889-94. PubMed ID: 1712181 [Abstract] [Full Text] [Related]
7. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Comin CE, Novelli L, Boddi V, Paglierani M, Dini S. Hum Pathol; 2001 May 31; 32(5):529-36. PubMed ID: 11381372 [Abstract] [Full Text] [Related]
8. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]. Pan QR, Zhang X, Xu ZF, Zheng S. Ai Zheng; 2002 Feb 31; 21(2):196-9. PubMed ID: 12479076 [Abstract] [Full Text] [Related]
9. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]. Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, Larbre H. Rev Mal Respir; 1994 Feb 31; 11(4):379-84. PubMed ID: 7973038 [Abstract] [Full Text] [Related]
10. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas. Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K. Anticancer Res; 1999 Feb 31; 19(4A):2673-8. PubMed ID: 10470218 [Abstract] [Full Text] [Related]
11. Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients. Kayser K, Böhm G, Blum S, Beyer M, Zink S, André S, Gabius HJ. J Pathol; 2001 Feb 31; 193(2):175-80. PubMed ID: 11180163 [Abstract] [Full Text] [Related]
12. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer]. Fujii M, Kiura K, Kamei H, Segawa Y. Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr 31; 27(4):452-5. PubMed ID: 2552209 [Abstract] [Full Text] [Related]
13. [Tumor marker in lung cancer]. Shijubo N, Abe S. Kokyu To Junkan; 1993 Jun 31; 41(6):551-5. PubMed ID: 7687790 [No Abstract] [Full Text] [Related]
14. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Ordóñez NG. Mod Pathol; 1998 Oct 31; 11(10):929-33. PubMed ID: 9796717 [Abstract] [Full Text] [Related]
15. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]. Yano H, Hino M, Nishiwaki Y, Kodama T, Hayashibe A, Kudo H, Inoue Y, Nishiyama Y, Sone Y, Oshima T. Gan To Kagaku Ryoho; 1987 Jan 31; 14(1):77-83. PubMed ID: 3026257 [Abstract] [Full Text] [Related]
16. [Immunohistochemical studies in the differential diagnosis of malignant fibrous histiocytoma]. Beham A, Wirnsberger G, Schmid C. Wien Klin Wochenschr; 1986 Sep 26; 98(18):617-22. PubMed ID: 3024416 [Abstract] [Full Text] [Related]
17. Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomas. Mayall FG, Jasani B, Gibbs AR. J Pathol; 1991 Dec 26; 165(4):325-8. PubMed ID: 1723753 [Abstract] [Full Text] [Related]
18. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N. Anticancer Res; 2003 Dec 26; 23(2A):885-93. PubMed ID: 12820318 [Abstract] [Full Text] [Related]
19. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects]. Chenard-Neu MP, Bellocq JP, Maier A, Batzenschlager A. Ann Pathol; 1990 Dec 26; 10(1):20-7. PubMed ID: 2328062 [Abstract] [Full Text] [Related]
20. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Pathol Int; 2007 Apr 26; 57(4):190-9. PubMed ID: 17316414 [Abstract] [Full Text] [Related] Page: [Next] [New Search]